|
||||||||||||||||||||||||||||||||||||||||||||
|
|
![]() Year : 2018 | Volume: 29 | Issue Number: 3 CASE REPORTShould antiviral monotherapy with nucleotide analogs be the primary treatment option for focal segmental glomerulosclerosis-related nephrotic syndrome in chronic hepatitis B infection? Javaid Muhammad M, Khatri Priyanka, Subramanian Srinivas
|
|